| Endogenous genes |
| 18S |
Hs99999901_s1 |
- |
| GAPDH |
Hs99999905_m1 |
glyceraldehyde-3-phosphate dehydrogenase |
| PI3K/AKT and RAS/MAPK signaling pathways |
| EGFR |
Hs01076078_m1 |
epidermal growth factor receptor |
| IGF1R |
Hs00609566_m1 |
insulin-like growth factor 1 receptor |
| MET |
Hs00179845_m1 |
met proto-oncogene |
| HER3 |
Hs00176538_m1 |
human epidermal growth factor receptor 3 |
| PIK3CA |
Hs00180679_m1 |
phosphatidylinositol-4.5-bisphosphate 3-kinase. catalytic subunit alpha |
| PTEN |
Hs00829813_s1 |
phosphatase and tensin homolog |
| AKT1 |
Hs00178289_m1 |
v-akt murine thymoma viral oncogene homolog 1 |
| MTOR |
Hs00234508_m1 |
mechanistic target of rapamycin (serine/threonine kinase) |
| BRAF |
Hs00269944_m1 |
v-raf murine sarcoma viral oncogene homolog B |
| KRAS |
Hs00364282_m1 |
Kirsten rat sarcoma viral oncogene homolog |
| MAPK1 |
Hs01046830_m1 |
mitogen-activated protein kinase 1 |
| MAPK3 |
Hs00385075_m1 |
mitogen-activated protein kinase 3 |
| FOS |
Hs00170630_m1 |
FBJ murine osteosarcoma viral oncogene homolog |
| MYC |
Hs00153408_m1 |
v-myc avian myelocytomatosis viral oncogene homolog |
| Cell cycle control |
| E2F1 |
Hs00153451_m1 |
E2F transcription factor 1 |
| CDK2 |
Hs01548894_m1 |
cyclin-dependent kinase 2 |
| CDK4 |
Hs00175935_m1 |
cyclin-dependent kinase 4 |
| CDK6 |
Hs01026372_m1 |
cyclin-dependent kinase 6 |
| CDKN1A |
Hs00355782_m1 |
cyclin-dependent kinase inhibitor 1A |
| CDKN2A |
Hs00923893_m1 |
cyclin-dependent kinase inhibitor 2A |
| CDKN1B |
Hs00153277_m1 |
cyclin-dependent kinase inhibitor 1B |
| CDKN1C |
Hs00175938_m1 |
cyclin-dependent kinase inhibitor 1C |
| CCNA1 |
Hs00171105_m1 |
cyclin A1 |
| CCNB1 |
Hs99999188_m1 |
cyclin B1 |
| CCND1 |
Hs00277039_m1 |
cyclin D1 |
| CCNE1 |
Hs00233356_m1 |
cyclin E1 |
| CHEK1 |
Hs00967506_m1 |
checkpoint kinase 1 |
| CHEK2 |
Hs00200485_m1 |
checkpoint kinase 2 |
| RB1 |
Hs01078066_m1 |
retinoblastoma 1 |
| TP53 |
Hs99999147_m1 |
tumor protein p53 |
| Apoptosis |
| BAX |
Hs00180269_m1 |
BCL2-associated X protein |
| BCL2 |
Hs00608023_m1 |
B-cell CLL/lymphoma 2 |
| CASP8 |
Hs01018151_m1 |
caspase 8 |
| CASP9 |
Hs00154260_m1 |
caspase 9 |
| CASP3 |
Hs00234387_m1 |
caspase 3 |
| XIAP |
Hs00745222_s1 |
X-linked inhibitor of apoptosis |
| Angiogenesis |
| NOS2 |
Hs01075529_m1 |
nitric oxide synthase 2. inducible |
| CDH1 |
Hs01023894_m1 |
cadherin 1, type 1, E-cadherin (epithelial) |
| PLAU |
Hs01547054_m1 |
plasminogen activator. urokinase |
| VEGF |
Hs00900055_m1 |
vascular endothelial growth factor A |
| MMP9 |
Hs00234579_m1 |
matrix metallopeptidase 9 |
| DNA repair |
| BRCA1 |
Hs00173237_m1 |
breast cancer 1 |
| PARP1 |
Hs00242302_m1 |
poly (ADP-ribose) polymerase 1 |
| PARP2 |
Hs00193931_m1 |
poly (ADP-ribose) polymerase 2 |
| Drug resistance |
| ABCB1 |
Hs00184491_m1 |
ATP-binding cassette, sub-family B (MDR/TAP), member 1 |
| ABCG2 |
Hs00184979_m1 |
ATP-binding cassette, sub-family G (BCRP1), member 2 |
